BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10845107)

  • 1. Mechanisms of guanylin action via cyclic GMP in the kidney.
    Forte LR; London RM; Krause WJ; Freeman RH
    Annu Rev Physiol; 2000; 62():673-95. PubMed ID: 10845107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylin peptides: cyclic GMP signaling mechanisms.
    Forte LR; Freeman RH; Krause WJ; London RM
    Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylin peptides: renal actions mediated by cyclic GMP.
    Forte LR; London RM; Freeman RH; Krause WJ
    Am J Physiol Renal Physiol; 2000 Feb; 278(2):F180-91. PubMed ID: 10662722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
    Forte LR
    Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and activity of OK-GC: a kidney receptor guanylate cyclase activated by guanylin peptides.
    London RM; Eber SL; Visweswariah SS; Krause WJ; Forte LR
    Am J Physiol; 1999 Jun; 276(6):F882-91. PubMed ID: 10362777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylin and related peptides.
    Bełtowski J
    J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
    Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
    Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
    Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
    Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intestinal guanylin system and seawater adaptation in eels.
    Takei Y; Yuge S
    Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity.
    Forte LR; Fan X; Hamra FK
    Am J Kidney Dis; 1996 Aug; 28(2):296-304. PubMed ID: 8768930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guanylin family: new intestinal peptides regulating salt and water homeostasis].
    Date Y; Nakazato M; Matsuo H
    Nihon Rinsho; 1998 Sep; 56(9):2427-32. PubMed ID: 9780732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family.
    Forte LR; Eber SL; Fan X; London RM; Wang Y; Rowland LM; Chin DT; Freeman RH; Krause WJ
    Endocrinology; 1999 Apr; 140(4):1800-6. PubMed ID: 10098518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems.
    Fan X; Wang Y; London RM; Eber SL; Krause WJ; Freeman RH; Forte LR
    Endocrinology; 1997 Nov; 138(11):4636-48. PubMed ID: 9348189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of uroguanylin and guanylin in vivo.
    Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
    Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal electrolyte effects of guanylin and uroguanylin.
    Sindić A; Schlatter E
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):10-5. PubMed ID: 17143065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
    Forte LR
    Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives.
    Fonteles MC; do Nascimento NR
    Can J Physiol Pharmacol; 2011 Aug; 89(8):575-85. PubMed ID: 21815750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of actions of guanylin peptides in the kidney.
    Sindić A; Schlatter E
    Pflugers Arch; 2005 Aug; 450(5):283-91. PubMed ID: 15952032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High salt intake increases uroguanylin expression in mouse kidney.
    Potthast R; Ehler E; Scheving LA; Sindic A; Schlatter E; Kuhn M
    Endocrinology; 2001 Jul; 142(7):3087-97. PubMed ID: 11416031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.